BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 27521309)

  • 1. Clonal Evolution in Multiple Myeloma.
    Fakhri B; Vij R
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S130-4. PubMed ID: 27521309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clonal evolution during long-term clinical course of multiple myeloma.
    Mishima Y; Mishima Y; Shirouchi Y; Nishimura N; Yokoyama M; Okabe T; Inoue N; Uryu H; Fukuta T; Hatake K; Terui Y
    Int J Hematol; 2021 Feb; 113(2):279-284. PubMed ID: 32864713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
    Gralewski JH; Post GR; van Rhee F; Yuan Y
    Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic heterogeneity in multiple myeloma.
    Szalat R; Munshi NC
    Curr Opin Genet Dev; 2015 Feb; 30():56-65. PubMed ID: 25982873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of clonal evolution in multiple myeloma.
    Furukawa Y; Kikuchi J
    Int J Hematol; 2020 Apr; 111(4):496-511. PubMed ID: 32026210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing next-generation sequencing in the management of multiple myeloma.
    Lionetti M; Neri A
    Expert Rev Mol Diagn; 2017 Jul; 17(7):653-663. PubMed ID: 28524737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic complexity of multiple myeloma and its clinical implications.
    Manier S; Salem KZ; Park J; Landau DA; Getz G; Ghobrial IM
    Nat Rev Clin Oncol; 2017 Feb; 14(2):100-113. PubMed ID: 27531699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma: charging toward a bright future.
    Katzel JA; Hari P; Vesole DH
    CA Cancer J Clin; 2007; 57(5):301-18. PubMed ID: 17855486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards Stratified Medicine in Plasma Cell Myeloma.
    Egan P; Drain S; Conway C; Bjourson AJ; Alexander HD
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine.
    Dutta AK; Alberge JB; Sklavenitis-Pistofidis R; Lightbody ED; Getz G; Ghobrial IM
    Nat Rev Clin Oncol; 2022 Apr; 19(4):223-236. PubMed ID: 35017721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients.
    Kortuem KM; Braggio E; Bruins L; Barrio S; Shi CS; Zhu YX; Tibes R; Viswanatha D; Votruba P; Ahmann G; Fonseca R; Jedlowski P; Schlam I; Kumar S; Bergsagel PL; Stewart AK
    Blood Cancer J; 2016 Feb; 6(2):e397. PubMed ID: 26918361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloma genetics and genomics: practice implications and future directions.
    Faiman B
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):436-40. PubMed ID: 25127058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Myeloma Genomics - A Concise Review.
    Castaneda O; Baz R
    Acta Med Acad; 2019 Apr; 48(1):57-67. PubMed ID: 31264433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Clonal Heterogeneity in Multiple Myeloma.
    Schinke C; Rasche L; Raab MS; Weinhold N
    Hematol Oncol Clin North Am; 2024 Apr; 38(2):461-476. PubMed ID: 38195308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple myeloma clonal evolution in homogeneously treated patients.
    Corre J; Cleynen A; Robiou du Pont S; Buisson L; Bolli N; Attal M; Munshi N; Avet-Loiseau H
    Leukemia; 2018 Dec; 32(12):2636-2647. PubMed ID: 29895955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Myeloma: Molecular Pathogenesis and Disease Evolution.
    Heider M; Nickel K; Högner M; Bassermann F
    Oncol Res Treat; 2021; 44(12):672-681. PubMed ID: 34749378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for multiple myeloma in the era of novel therapies.
    Ziogas DC; Dimopoulos MA; Kastritis E
    Expert Rev Hematol; 2018 Nov; 11(11):863-879. PubMed ID: 30334460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation Sequencing Informing Therapeutic Decisions and Personalized Approaches.
    Szalat R; Munshi NC
    Am Soc Clin Oncol Educ Book; 2016; 35():e442-8. PubMed ID: 27249752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome instability in multiple myeloma.
    Neuse CJ; Lomas OC; Schliemann C; Shen YJ; Manier S; Bustoros M; Ghobrial IM
    Leukemia; 2020 Nov; 34(11):2887-2897. PubMed ID: 32651540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic profiling of multiple myeloma: New insights and modern technologies.
    Hultcrantz M; Yellapantula V; Rustad EH
    Best Pract Res Clin Haematol; 2020 Mar; 33(1):101153. PubMed ID: 32139018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.